Polyphenols of Hibiscus sabdariffa improved diabetic nephropathy via regulating the pathogenic markers and kidney functions of type 2 diabetic rats

Journal of Functional Foods

Volumn 5, Issue 2, 2013, Pages 810-819

  Yang, Yi Sun ^a,b   Huang, Chien Ning ^a,b   Wang, Chau Jong ^b   Lee, Yi Ju ^a   Chen, Mu Lin ^b   Peng, Chiung Huei ^c  

^a CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c HUNGKUANG UNIVERSITY   (Taiwan)

Author keywords

Diabetic nephropathy; Hibiscus sabdariffa polyphenol extract; Type 2 diabetes

Indexed keywords

ANIMALIA; HIBISCUS SABDARIFFA; RATTUS;

EID: 84876719418     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2013.01.027     Document Type: Article

References (37)

1. Balakumar P., Arora M.K., Reddy J., Anand-Srivastava M.B. Pathophysiology of diabetic nephropathy: Involvement of multifaceted signalling mechanism. Journal of Cardiovascular Pharmacology 2009, 54:129-138.
2. Chao C.Y., Mong M.C., Chan K.C., Yin M.C. Antiglycative and anti-inflammatory effects of caffeic acid and ellagic acid in kidney of diabetic mice. Molecular Nutrition & Food Research 2010, 54:388-395.
3. Chen S.C., Guh J.Y., Hwang C.C., Chiou S.J., Lin T.D., Ko Y.M., Huang J.S., Yang Y.L., Chuang L.Y. Advanced glycation end-products activate extracellular signal-regulated kinase via the oxidative stress-EGF receptor pathway in renal fibroblasts. Journal of Cellular Biochemistry 2010, 109:38-48.
4. Dai H.Y., Zheng M., Tang R.N., Ni J., Ma K.L., Li Q., Liu B.C. Effects of angiotensin receptor blocker on phenotypic alterations of podocytes in early diabetic nephropathy. The American Journal of the Medical Sciences 2011, 341:207-214.
5. Gasic-Milenkovic J., Loske C., Munch G. Advanced glycation endproducts cause lipid peroxidation in the human neuronal cell line SH-SY5Y. Journal of Alzheimer's Disease 2003, 5:25-30.
6. Huang C.N., Chan K.C., Lin W.T., Su S.L., Wang C.J., Peng C.H. Hibiscus sabdariffa inhibits vascular smooth muscle cell proliferation and migration induced by high glucoses-A mechanism involves connective tissue growth factor signals. Journal of Agricultural and Food Chemistry 2009, 57:3073-3079.
7. Huang D.W., Shen S.C. Caffeic acid and cinnamic acid ameliorate glucose metabolism via modulating glycogenesis and gluconeogenesis in insulin-resistant mouse hepatocytes. Journal of Functional Foods 2012, 4:358-366.
8. Ichinose K., Maeshima Y., Yamamoto Y., Kinomura M., Hirokoshi K., Kitayama H., Takazawa Y., Sugiyama H., Yamasaki Y., Agata N., Makino H. 2-(8-Hydroxy-6-methoxy-1-oxo-1h-2-benzopyran-3-yl) propionic acid, an inhibitor of angiogenesis, ameliorates renal alterations in obese type 2 diabetic mice. Diabetes 2006, 55:1232-1242.
9. Ihm S.H., Chang K., Kim H.Y., Baek S.H., Youn H.J., Seung K.B., Kim J.H. Peroxisome proliferator-activated receptor-gamma activation attenuates cardiac fibrosis in type 2 diabetic rats: The effect of rosiglitazone on myocardial expression of receptor for advanced glycation end products and of connective tissue growth factor. Basic Research in Cardiology 2010, 105:399-407.
10. Kalaitzidis R., Bakris G.L. Effects of angiotensin II receptor blockers on diabetic nephropathy. Journal of Hypertension. Supplement 2009, 27:S15-S21.
11. Karthikesan K., Pari L., Menon V.P. Protective effect of tetrahydrocurcumin and chlorogenic acid against streptozotocin-nicotinamide generated oxidative stress induced diabetes. Journal of Functional Foods 2010, 2:134-142.
12. Kim J.H., Kang M.J., Choi H.N., Jeong S.M., Lee Y.M., Kim J.I. Quercetin attenuates fasting and postprandial hyperglycemia in animal models of diabetes mellitus. Nutrition Research and Practice 2011, 5:107-111.
13. Kobayashi T., Inoue T., Okada H., Kikuta T., Kanno Y., Nishida T., Takigawa M., Sugaya T., Suzuki H. Connective tissue growth factor mediates the profibrotic effects of transforming growth factor-beta produced by tubular epithelial cells in response to high glucose. Clinical and Experimental Nephrology 2005, 9:114-121.
14. Latha R.C., Daisy P. Insulin-secretagogue, antihyperlipidemic and other protective effects of gallic acid isolated from Terminalia bellerica Roxb. in streptozotocin-induced diabetic rats. Chemico-Biological Interactions 2011, 189:112-118.
15. Lee C.I., Guh J.Y., Chen H.C., Lin K.H., Yang Y.L., Hung W.C., Lai Y.H., Chuang L.Y. Leptin and connective tissue growth factor in advanced glycation end-product-induced effects in NRK-49F cells. Journal of Cellular Biochemistry 2004, 93:940-950.
16. Lee W.C., Wang C.J., Chen Y.H., Hsu J.D., Cheng S.Y., Chen H.C., Lee H.J. Polyphenol extracts from Hibiscus sabdariffa Linnaeus attenuate nephropathy in experimental type 1 diabetes. Journal of Agricultural and Food Chemistry 2009, 57:2206-2210.
17. Levey A.S., Eckardt K.U., Tsukamoto Y., Levin A., Coresh J., Rossert J., De Zeeuw D., Hostetter T.H., Lameire N., Eknoyan G. Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney International 2005, 67:2089-2100.
18. Li J., Liu N.F., Wei Q. Effect of rosiglitazone on cardiac fibroblast proliferation, nitric oxide production and connective tissue growth factor expression induced by advanced glycation end-products. The Journal of International Medical Research 2008, 36:329-335.
19. Lin H.H., Chen J.H., Wang C.J. Chemopreventive properties and molecular mechanisms of the bioactive compounds in Hibiscus Sabdariffa Linne. Current Medicinal Chemistry 2011, 18:1245-1254.
20. Lin C.Y., Tsai S.J., Huang C.S., Yin M.C. Antiglycative effects of protocatechuic acid in the kidneys of diabetic mice. Journal of Agricultural and Food Chemistry 2011, 59:5117-5124.
21. Moriya T., Tsuchiya A., Okizaki S., Hayashi A., Tanaka K., Shichiri M. Glomerular hyperfiltration and increased glomerular filtration surface are associated with renal function decline in normo- and microalbuminuric type 2 diabetes. Kidney International 2012, 81:486-493.
22. Nakagawa T. A new mouse model resembling human diabetic nephropathy: Uncoupling of VEGF with eNOS as a novel pathogenic mechanism. Clinical Nephrology 2009, 71:103-109.
23. Nasu T., Maeshima Y., Kinomura M., Hirokoshi-Kawahara K., Tanabe K., Sugiyama H., Sonoda H., Sato Y., Makino H. Vasohibin-1, a negative feedback regulator of angiogenesis, ameliorates renal alterations in a mouse model of diabetic nephropathy. Diabetes 2009, 58:2365-2375.
24. National Kidney Foundation K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. American Journal of Kidney Diseases 2002, 39:S1-S266.
25. Ohtomo S., Ito M., Izuhara Y., Van Ypersele De Strihou C., Miyata T. Reduction of albuminuria by angiotensin receptor blocker beyond blood pressure lowering: Evaluation in megsin/receptor for advanced glycation end products/inducible nitric oxide synthase triple transgenic diabetic nephropathy mouse model. Nephrology 2008, 13:517-521.
26. Park C.H., Noh J.S., Yamabe N., Kang K.S., Tanaka T., Yokozawa T. Beneficial effect of 7-O-galloyl-d-sedoheptulose on oxidative stress and hepatic and renal changes in type 2 diabetic db/db mice. European Journal of Pharmacology 2010, 640:233-242.
27. Peng C.H., Chyau C.C., Chan K.C., Chan T.H., Wang C.J., Huang C.N. Hibiscus sabdariffa polyphenolic extract inhibits hyperglycemia, hyperlipidemia, and glycation-oxidative stress while improving insulin resistance. Journal of Agricultural and Food Chemistry 2011, 59:9901-9909.
28. Punithavathi V.R., Prince P.S., Kumar R., Selvakumari J. Antihyperglycaemic, antilipid peroxidative and antioxidant effects of gallic acid on streptozotocin induced diabetic Wistar rats. European Journal of Pharmacology 2011, 650:465-471.
29. Sourris K.C., Forbes J.M. Interactions between advanced glycation end-products (AGE) and their receptors in the development and progression of diabetic nephropathy - Are these receptors valid therapeutic targets. Current Drug Targets 2009, 10:42-50.
30. Stegbauer J., Coffman T.M. New insights into angiotensin receptor actions: From blood pressure to aging. Current Opinion in Nephrology and Hypertension 2011, 20:84-88.
31. Tanabe K., Maeshima Y., Ichinose K., Kitayama H., Takazawa Y., Hirokoshi K., Kinomura M., Sugiyama H., Makino H. Endostatin peptide, an inhibitor of angiogenesis, prevents the progression of peritoneal sclerosis in a mouse experimental model. Kidney International 2007, 71:227-238.
32. Tsuchida K., Makita Z., Yamagishi S., Atsumi T., Miyoshi H., Obara S., Ishida M., Ishikawa S., Yasumura K., Koike T. Suppression of transforming growth factor beta and vascular endothelial growth factor in diabetic nephropathy in rats by a novel advanced glycation end product inhibitor, OPB-9195. Diabetologia 1999, 42:579-588.
33. Wang S., Mitu G.M., Hirschberg R. Osmotic polyuria: An overlooked mechanism in diabetic nephropathy. Nephrology Dialysis Transplantation 2008, 23:2167-2172.
34. Zeisberg E.M., Potenta S.E., Sugimoto H., Zeisberg M., Kalluri R. Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition. Journal of the American Society of Nephrology 2008, 19:2282-2287.
35. Zhou G., Li C., Cai L. Advanced glycation end-products induce connective tissue growth factor-mediated renal fibrosis predominantly through transforming growth factor beta-independent pathway. The American Journal of Pathology 2004, 165:2033-2043.
36. Zhou L., Xue H., Yuan P., Ni J., Yu C., Huang Y., Lu L.M. Angiotensin AT1 receptor activation mediates high glucose-induced epithelial-mesenchymal transition in renal proximal tubular cells. Clinical and Experimental Pharmacology & Physiology 2010, 37:e152-e157.
37. Zhu Y., Zhang Y., Liu Y., Chu H., Duan H. Synthesis and biological activity of trans-tiliroside derivatives as potent anti-diabetic agents. Molecules 2010, 15:9174-9183.